{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:42:52Z","timestamp":1772134972876,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"DOI":"10.1038\/s41435-025-00335-5","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:21:39Z","timestamp":1749525699000},"page":"413-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polygenic prediction of cellular immune responses to mumps vaccine"],"prefix":"10.1038","volume":"26","author":[{"given":"Brandon J.","family":"Coombes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-9214","authenticated-orcid":false,"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Schaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-4967","authenticated-orcid":false,"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"335_CR1","unstructured":"Centers for Disease Control and Prevention. Mumps cases and outbreaks. US: Centers for Disease Control and Prevention; 2022."},{"key":"335_CR2","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1016\/j.vaccine.2023.09.001","volume":"41","author":"IG Ovsyannikova","year":"2023","unstructured":"Ovsyannikova IG, Haralambieva IH, Schaid DJ, Warner ND, Poland GA, Kennedy RB. Genome-wide determinants of cellular immune responses to mumps vaccine. Vaccine. 2023;41:6579\u201388.","journal-title":"Vaccine"},{"key":"335_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.vaccine.2012.01.025","volume":"30","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Haralambieva IH, O\u2019Byrne MM, Jacobson RM, Pankratz VS, et al. Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine. 2012;30:2159\u201367.","journal-title":"Vaccine"},{"key":"335_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2172-11-48","volume":"11","author":"VS Pankratz","year":"2010","unstructured":"Pankratz VS, Vierkant RA, O\u2019Byrne MM, Ovsyannikova IG, Poland GA. Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment. BMC Immunol. 2010;11:48.","journal-title":"BMC Immunol"},{"key":"335_CR5","doi-asserted-by":"publisher","first-page":"e1010907","DOI":"10.1371\/journal.pgen.1010907","volume":"19","author":"LG Fritsche","year":"2023","unstructured":"Fritsche LG, Nam K, Du J, Kundu R, Salvatore M, Shi X, et al. Uncovering associations between pre-existing conditions and COVID-19 severity: a polygenic risk score approach across three large biobanks. PLoS Genet. 2023;19:e1010907.","journal-title":"PLoS Genet"},{"key":"335_CR6","doi-asserted-by":"crossref","unstructured":"Bountress KE, Bustamante D, Ahangari M, Aliev F, Aggen SH, Lancaster E et al. The impact of the COVID-19 pandemic on alcohol use disorder symptoms: testing interactions with polygenic risk. J Am Coll Health. 2024;73:1\u20136.","DOI":"10.1080\/07448481.2024.2308255"},{"key":"335_CR7","doi-asserted-by":"crossref","unstructured":"Lluci\u00e0-Carol L, Mui\u00f1o E, Cullell N, C\u00e1rcel-M\u00e1rquez J, Lled\u00f3s M, Gallego-Fabrega C et al. Genetic architecture of ischaemic strokes after COVID-19 shows similarities with large vessel strokes. Int J Mol Sci. 2023;24:13452.","DOI":"10.3390\/ijms241713452"},{"key":"335_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30675-z","volume":"13","author":"AC Fahed","year":"2022","unstructured":"Fahed AC, Philippakis AA, Khera AV. The potential of polygenic scores to improve cost and efficiency of clinical trials. Nat Commun. 2022;13:2922.","journal-title":"Nat Commun"},{"key":"335_CR9","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","volume":"36","author":"GA Poland","year":"2017","unstructured":"Poland GA, Ovsyannikova IG, Kennedy RB. Personalized vaccinology: a review. Vaccine. 2017;36:5350\u20137.","journal-title":"Vaccine"},{"key":"335_CR10","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1016\/j.vaccine.2012.04.055","volume":"30","author":"IG Ovsyannikova","year":"2012","unstructured":"Ovsyannikova IG, Kennedy RB, O\u2019Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine. 2012;30:4182\u20139.","journal-title":"Vaccine"},{"key":"335_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","volume":"136","author":"IH Haralambieva","year":"2017","unstructured":"Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Zimmermann MT, Grill DE, et al. Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. Hum Genet. 2017;136:421\u201335.","journal-title":"Hum Genet"},{"key":"335_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108912","volume":"234","author":"MM Riggenbach","year":"2022","unstructured":"Riggenbach MM, Haralambieva IH, Ovsyannikova IG, Schaid DJ, Poland GA, Kennedy RB. Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents. Clin Immunol. 2022;234:108912.","journal-title":"Clin Immunol"},{"key":"335_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2012.08.021","volume":"510","author":"IG Ovsyannikova","year":"2012","unstructured":"Ovsyannikova IG, Haralambieva IH, Kennedy RB, Pankratz VS, Vierkant RA, Jacobson RM, et al. Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination. Gene. 2012;510:59\u201365.","journal-title":"Gene"},{"key":"335_CR14","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00439-012-1179-x","volume":"131","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Jacobson RM, et al. Genome-wide genetic associations with IFNgamma response to smallpox vaccine. Hum Genet. 2012;131:1433\u201351.","journal-title":"Hum Genet"},{"key":"335_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/infdis\/jix538","volume":"217","author":"EA Voigt","year":"2018","unstructured":"Voigt EA, Haralambieva IH, Larrabee BL, Kennedy RB, Ovsyannikova IG, Schaid DJ, et al. Polymorphisms in the Wilms tumor gene are associated with interindividual variations in rubella virus-specific cellular immunity after measles-mumps-rubella II vaccination. J Infect Dis. 2018;217:560\u20136.","journal-title":"J Infect Dis"},{"key":"335_CR16","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00439-012-1174-2","volume":"131","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Poland GA. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet. 2012;131:1403\u201321.","journal-title":"Hum Genet"},{"key":"335_CR17","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Sch\u00f6nherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284\u20137.","journal-title":"Nat Genet"},{"key":"335_CR18","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1101\/gr.094052.109","volume":"19","author":"DH Alexander","year":"2009","unstructured":"Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 2009;19:1655\u201364.","journal-title":"Genome Res"},{"key":"335_CR19","doi-asserted-by":"crossref","unstructured":"Choi SW, O\u2019Reilly PF PRSice-2: polygenic risk score software for biobank-scale data. Gigascience 2019;8:giz082.","DOI":"10.1093\/gigascience\/giz082"},{"key":"335_CR20","doi-asserted-by":"publisher","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","volume":"49","author":"M Ghoussaini","year":"2021","unstructured":"Ghoussaini M, Mountjoy E, Carmona M, Peat G, Schmidt EM, Hercules A, et al. Open targets genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2021;49:D1311\u2013d1320.","journal-title":"Nucleic Acids Res"},{"key":"335_CR21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41588-021-00945-5","volume":"53","author":"E Mountjoy","year":"2021","unstructured":"Mountjoy E, Schmidt EM, Carmona M, Schwartzentruber J, Peat G, Miranda A, et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat Genet. 2021;53:1527\u201333.","journal-title":"Nat Genet"},{"key":"335_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1001-166","volume":"29","author":"S Hadano","year":"2001","unstructured":"Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166\u201373.","journal-title":"Nat Genet"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00335-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:28:34Z","timestamp":1757183314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00335-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1038\/s41435-025-00335-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.23.24303277","asserted-by":"object"}]},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Poland provides consultative advice to AiZtech; Emergent, GlaxoSmithKline, Invivyd, Merck & Co. Inc., Moderna, Novavax, Syneos Health, and Valneva. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. Poland, Ovsyannikova and Kennedy hold patents related to vaccinia, influenza, and measles peptide vaccines. Poland, Ovsyannikova and Kennedy have received grant funding from ICW Ventures for preclinical studies on a peptide-based COVID-19 vaccine. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. Poland is an adviser to the White House and World Health Organization on COVID-19 vaccines and monkeypox, respectively. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}